tripalmitin has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berstan, R; Clark, A; Currie, JM; Evershed, R; Fielding, BA; Moffitt, JH | 1 |
1 other study(ies) available for tripalmitin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; COS Cells; Fatty Acids, Nonesterified; Glucose; Insulin; Insulin Secretion; Insulinoma; Linoleic Acid; Mice; Oleic Acid; Palmitic Acid; Pancreatic Neoplasms; Phospholipids; Triglycerides | 2005 |